Skip to main content
. 2011 Nov 28;9:204. doi: 10.1186/1479-5876-9-204

Figure 1.

Figure 1

Dosing and testing schedule: CA184-004. *Tumor biopsy was performed at baseline and 24 to 72 hours after the second dose of ipilimumab. Influenza/pneumococcal booster administered 5 days after first dose of ipilimumab. Q3W: every 3 weeks; Q12W: every 12 weeks.